NYSE:HHLA • KYG397141030
The current stock price of HHLA is 10.75 USD. In the past month the price decreased by -0.09%. In the past year, price increased by 5.7%.
ChartMill assigns a technical rating of 6 / 10 to HHLA. When comparing the yearly performance of all stocks, HHLA turns out to be only a medium performer in the overall market: it outperformed 52.03% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to HHLA. HHLA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months HHLA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -152.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.25% | ||
| ROE | -1.92% | ||
| Debt/Equity | 0.06 |
HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm intends to acquire one or more healthcare businesses, with a focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets.
HH&L ACQUISITION CO -CLASS A
C/O Sapphire Qi Li, One Exchange Square, 8 Connaught Place Suite 3508
HK
CEO: Richard Qi Li
Employees: 0
Phone: 85266796578
HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm intends to acquire one or more healthcare businesses, with a focus on healthcare or healthcare-related companies in Asian markets with a focus on the Greater China market, or global healthcare or healthcare-related companies with a meaningful growth thesis in the Greater China or Asian markets.
The current stock price of HHLA is 10.75 USD. The price decreased by -0.23% in the last trading session.
HHLA does not pay a dividend.
HHLA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
HH&L ACQUISITION CO -CLASS A (HHLA) currently has 0 employees.
HH&L ACQUISITION CO -CLASS A (HHLA) will report earnings on 2022-02-11.